Clinical Trial Update: Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sublingual fentanyl spray for acute pain in emergency department patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Sublingual fentanyl spray (fentanyl)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Acute Pain | Phase 2 | Status: WITHDRAWN